Railway Automated Inspection Equipment Market Value Projected To Reach US$ 3,458 Million By 2027 Covering Covid-19 Analysis: Acumen Research and Consulting
June 30, 2021 21:32 ET
|
Acumen Research and Consulting
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- The Global Railway Automated Inspection Equipment Market is expected to grow at a CAGR of around 5.2% from 2020 to 2027 and reach the market value of...
North America Railway Automated Inspection Equipment Market to Garner $831.6 Million by 2027: Says Allied Market Research
June 21, 2021 11:53 ET
|
Allied Market Research
Portland, OR, June 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global North America railway automated inspection equipment market was pegged at...
World Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory Board
February 09, 2017 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Feb. 09, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications...
PetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey Broderick, to Join the Company as the New President
February 03, 2017 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Feb. 03, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications...
PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.
January 10, 2017 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Jan. 10, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 07, 2016 08:50 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 07, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA Submission
December 06, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 06, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product Offerings
December 01, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 01, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™
November 15, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Nov. 15, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...